Ventas (Ventas) EPS (Basic) : $-0.11 (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ventas EPS (Basic)?

Ventas's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was $-0.23. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.11.

Ventas's EPS (Diluted) for the three months ended in Dec. 2023 was $-0.23. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.11.

Ventas's EPS without NRI for the three months ended in Dec. 2023 was $-0.28. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.23.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ventas's highest 3-Year average EPS without NRI Growth Rate was 34.40% per year. The lowest was -34.40% per year. And the median was 2.95% per year.

Ventas EPS (Basic) Historical Data

The historical data trend for Ventas's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventas EPS (Basic) Chart

Ventas Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

1.18

0.13

-0.12

-0.10

Ventas Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.11	0.04	0.26	-0.18	-0.23

Ventas EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ventas's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-40.973	-	0)	/	401.809
	=	-0.10

Ventas's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-90.819	-	0)	/	402.964
	=	-0.23

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11

Ventas (NYSE:VTR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ventas EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Ventas's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventas (Ventas) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (NYSE:VTR) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

VEN:Germany V1TA34:Brazil

Address

353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654

Website

https://www.ventasreit.com

Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.

Executives

Walter C Rakowich	director	14100 E 35TH PL, AURORA CO 80011
Debra A Cafaro	director, officer: Chairman, President and CEO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sumit Roy	director	600 LA TERRAZA BOULEVARD, ESCONDIDO CA 92025
Michael J Embler	director	C/O NMI HOLDINGS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Robert D. Reed	director	47 DONALD DRIVE, ORINDA CA 94563
James D Shelton	director	3901 TURTLE CREEK BLVD. #12, DALLAS TX 75219
Richard I Gilchrist	director	5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Robert F Probst	officer: EVP, CFO and Acting CAO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Gregory R Liebbe	officer: SVP, Chief Accounting Officer	500 N. HURSTBOURNE PARKWAY, SUITE 200, LOUISVILLE KY 40222
Maurice S Smith	director	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Marguerite M Nader	director	2S601 AVENUE LA TOURS, OAK BROOK IL 60523
Carey S. Roberts	officer: EVP and GC	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
James Justin Hutchens	officer: EVP Sr Housing North America	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
John D. Cobb	officer: SVP & Chief Investment Officer	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sean P. Nolan	director	C/O INTERMUNE, INC., 3280 BAYSHORE BLVD., BRISBANE CA 94005